Found: 6
Select item for more details and to access through your institution.
Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.
- Published in:
- Molecular Genetics & Genomic Medicine, 2022, v. 10, n. 12, p. 1, doi. 10.1002/mgg3.2071
- By:
- Publication type:
- Article
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1330481
- By:
- Publication type:
- Article
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 7, p. e207566, doi. 10.1001/jamanetworkopen.2020.7566
- By:
- Publication type:
- Article
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high‐grade serous ovarian cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 565, doi. 10.1002/ijc.32935
- By:
- Publication type:
- Article
Multisite analysis of high‐grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2670, doi. 10.1002/ijc.32288
- By:
- Publication type:
- Article
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 12, p. 1554, doi. 10.3390/cells8121554
- By:
- Publication type:
- Article